Related Experiment Video
Updated: Nov 20, 2025

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
Published on: August 11, 2023
NF-κB subunit RELA suppression of mucosa-associated lymphoid tissue lymphoma translocation protein 1 expression in
Takaomi Nozawa1, Nozomi Mihara-Tomiyama1, Tadashige Chiba1
1Department of Biochemistry, The Nippon Dental University School of Life Dentistry at Tokyo, 1-9-20 Fujimi, Chiyoda-ku, Tokyo, 102-8159, Japan.
Abstract:
Loss of mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) expression closely associates with increased aggressive behaviors of oral carcinoma cells. It emphasizes that a mechanism to suppress the expression is an important subject for understanding carcinoma progression pathway. However, nothing is known at present. This study conducted on transcriptional regulation of the gene down-regulation. Reporter assays showed the presence of the silencer region between +402 and +501 region of MALT1 gene in oral carcinoma cells. It encoded a binding site of nuclear factor-κB subunit, RELA. RELA binding to the site was confirmed by the chromatin immunoprecipitation analyses, and deletion and mutations of the site significantly decreased the RELA binding. Short interfering RNAs for RELA up-regulated reporter gene and endogenous MALT1 protein expressions, and deletion and mutations of RELA binding site increased reporter gene expression. These results demonstrated RELA-binding to the site suppresses MALT1 expression that may facilitate oral carcinoma progression.
Insights
Nuclear factor-kappaB (NF-κB) subunit RELA suppresses mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) expression in oral carcinoma. This suppression may drive oral cancer progression, highlighting a new therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Loss of MALT1 expression correlates with aggressive oral carcinoma.
- Understanding MALT1 down-regulation mechanisms is crucial for oral cancer progression pathways.
- Transcriptional regulation of MALT1 gene down-regulation is currently unknown.
Purpose of the Study:
- To investigate the transcriptional regulation of MALT1 gene down-regulation in oral carcinoma.
- To identify regulatory elements and transcription factors involved in MALT1 suppression.
Main Methods:
- Reporter assays to identify silencer regions in the MALT1 gene.
- Chromatin immunoprecipitation (ChIP) to confirm transcription factor binding.
- Site-directed mutagenesis and deletion analysis of the MALT1 gene.
- Short interfering RNA (siRNA) knockdown of RELA.
Main Results:
- A silencer region between +402 and +501 of the MALT1 gene was identified.
- This region contains a binding site for nuclear factor-kappaB (NF-κB) subunit RELA.
- RELA binding was confirmed by ChIP and reduced by site mutations.
- RELA knockdown and MALT1 binding site mutations increased MALT1 expression.
Conclusions:
- RELA binds to a specific site on the MALT1 gene, suppressing its expression.
- This RELA-mediated suppression of MALT1 may contribute to oral carcinoma progression.
- Targeting the RELA-MALT1 interaction could offer a therapeutic strategy for oral cancer.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation
Non-LTR Retrotransposons
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

